GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Hadasit Bio Holdings Ltd (XTAE:HDST-M) » Definitions » COGS-to-Revenue

Hadasit Bio Holdings (XTAE:HDST-M) COGS-to-Revenue : 0.00 (As of Dec. 2024)


View and export this data going back to 2006. Start your Free Trial

What is Hadasit Bio Holdings COGS-to-Revenue?

Hadasit Bio Holdings's Cost of Goods Sold for the six months ended in Dec. 2024 was ₪0.00 Mil. Its Revenue for the six months ended in Dec. 2024 was ₪-0.10 Mil.

Hadasit Bio Holdings's COGS to Revenue for the six months ended in Dec. 2024 was 0.00.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Hadasit Bio Holdings's Gross Margin % for the six months ended in Dec. 2024 was N/A%.


Hadasit Bio Holdings COGS-to-Revenue Historical Data

The historical data trend for Hadasit Bio Holdings's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hadasit Bio Holdings COGS-to-Revenue Chart

Hadasit Bio Holdings Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
COGS-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Hadasit Bio Holdings Semi-Annual Data
Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
COGS-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Hadasit Bio Holdings COGS-to-Revenue Calculation

Hadasit Bio Holdings's COGS to Revenue for the fiscal year that ended in Dec. 2024 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=0 / 0
=

Hadasit Bio Holdings's COGS to Revenue for the quarter that ended in Dec. 2024 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=0 / -0.098
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Hadasit Bio Holdings  (XTAE:HDST-M) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Hadasit Bio Holdings's Gross Margin % for the six months ended in Dec. 2024 is calculated as:

Gross Margin %=1 - COGS to Revenue
=1 - Cost of Goods Sold / Revenue
=1 - 0 / -0.098
=N/A %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.


Hadasit Bio Holdings COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Hadasit Bio Holdings's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Hadasit Bio Holdings Business Description

Traded in Other Exchanges
N/A
Address
5th Floor, Jerusaelm Bio-Park, Hadassah Ein-Kerem Campus, Jerusalem, ISR, 91120
Hadasit Bio Holdings Ltd serves as a precedent in the field of biotech financing. It is engaged in the advancement and enhancement of its portfolio companies. Its portfolio companies are involved in the field of medical and biotechnological research and production and distribution of the results of the research and development done in these areas.

Hadasit Bio Holdings Headlines

No Headlines